UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2017-06, Vol.69 (6), p.1306-1312

2017

Volltextzugriff (PDF)

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Circulation. Heart failure, 2013-09, Vol.6 (5), p.953-963

2013

Volltextzugriff (PDF)

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

American journal of respiratory and critical care medicine, 2010-07, Vol.182 (2), p.252-260

2010

Volltextzugriff (PDF)

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Arthritis care & research (2010), 2017-11, Vol.69 (11), p.1764-1770

2017

Volltextzugriff (PDF)

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Journal of rheumatology, 2010-01, Vol.37 (1), p.98-104

2010

Volltextzugriff (PDF)

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Journal of rheumatology, 2009-03, Vol.36 (3), p.576-582

2009

Volltextzugriff (PDF)

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Annals of the rheumatic diseases, 2011-06, Vol.70 (6), p.1104-1107

2011

Volltextzugriff (PDF)

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Seminars in arthritis and rheumatism, 2016-10, Vol.46 (2), p.196-199

2016

Volltextzugriff (PDF)

Late-age onset systemic sclerosis

Journal of rheumatology, 2011-07, Vol.38 (7), p.1317-1325

2011

Volltextzugriff (PDF)

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Arthritis care & research (2010), 2016-08, Vol.68 (8), p.1150-1157

2016

Volltextzugriff (PDF)

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol

Journal of rheumatology, 2009-10, Vol.36 (10), p.2244-2249

2009

Volltextzugriff (PDF)

Scleroderma patients with combined pulmonary hypertension and interstitial lung disease

Journal of rheumatology, 2003-11, Vol.30 (11), p.2398

2003

Volltextzugriff (PDF)

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Medicine (Baltimore), 2014-07, Vol.93 (5), p.177-185

2014

Volltextzugriff (PDF)

Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma

Journal of rheumatology, 2006-02, Vol.33 (2), p.269

2006

Volltextzugriff (PDF)

Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma

Arthritis & rheumatology (Hoboken, N.J.), 2015-04, Vol.67 (4), p.1053-1061

2015

Volltextzugriff (PDF)

Deficient Smad7 Expression: A Putative Molecular Defect in Scleroderma

Proceedings of the National Academy of Sciences - PNAS, 2002-03, Vol.99 (6), p.3908-3913

2002

Volltextzugriff (PDF)

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension

Circulation (New York, N.Y.), 2018-05, Vol.137 (22), p.2360-2370

2018

Volltextzugriff (PDF)

The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma‐Associated Raynaud's Phenomenon: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

Arthritis & rheumatology (Hoboken, N.J.), 2017-08, Vol.69 (8), p.1661-1669

2017

Volltextzugriff (PDF)

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial

Journal of rheumatology, 2005-05, Vol.32 (5), p.832

2005

Volltextzugriff (PDF)

Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality

Arthritis & rheumatology (Hoboken, N.J.), 2022-05, Vol.74 (5), p.849-859

2022

Volltextzugriff (PDF)

Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception

Rheumatology (Oxford, England), 2015-08, Vol.54 (8), p.1443-1447

2015

Volltextzugriff (PDF)

Age and Risk of Pulmonary Arterial Hypertension in Scleroderma

Chest, 2003-12, Vol.124 (6), p.2098-2104

2003

Volltextzugriff (PDF)

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Annals of the rheumatic diseases, 2011-01, Vol.70 (1), p.32-38

2011

Volltextzugriff (PDF)

Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California–Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis

Arthritis care & research (2010), 2022-03, Vol.74 (3), p.442-450

2022

Volltextzugriff (PDF)

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis

Journal of rheumatology, 2006-09, Vol.33 (9), p.1886

2006

Volltextzugriff (PDF)

1 – 25 von 133

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(133)

Sprache

Englisch
(133)

Erscheinungsjahr

n.n

Thema

Humans
(133)
Female
(124)
Science & Technology
(124)
Life Sciences & Biomedicine
(123)
Male
(115)
Adult
(108)
Rheumatology
(84)
Biological And Medical Sciences
(69)
Medical Sciences
(68)
Aged
(63)
Scleroderma, Systemic - Complications
(46)
Scleroderma
(42)
Scleroderma, Systemic - Physiopathology
(27)
General & Internal Medicine
(24)
Diseases Of The Osteoarticular System
(23)
Treatment Outcome
(23)
Systemic Sclerosis
(21)
Retrospective Studies
(20)
Medicine, General & Internal
(19)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Brief Report: Anti–RNPC‐3 Antibodies As a Marker of Cancer‐Associated Scleroderma

Right ventricular dysfunction in systemic sclerosis-associated pulmonary arterial hypertension

Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension

Association of Fibrosing Myopathy in Systemic Sclerosis and Higher Mortality

Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension

Abnormalities in the regulators of angiogenesis in patients with scleroderma

Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis

Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series

Late-age onset systemic sclerosis

Symptomatic and Electrodiagnostic Features of Peripheral Neuropathy in Scleroderma

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol

Scleroderma patients with combined pulmonary hypertension and interstitial lung disease

Severity of systemic sclerosis-associated pulmonary arterial hypertension in African Americans

Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma

Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma

Deficient Smad7 Expression: A Putative Molecular Defect in Scleroderma

Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis–Associated Versus Idiopathic Pulmonary Arterial Hypertension

The Therapeutic Efficacy of Botulinum Toxin in Treating Scleroderma‐Associated Raynaud's Phenomenon: A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial

Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial

Diastolic Dysfunction in Systemic Sclerosis: Risk Factors and Impact on Mortality

Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception

Age and Risk of Pulmonary Arterial Hypertension in Scleroderma

Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial

Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California–Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis

Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis

Aktive Filter

Suchergebnisse filtern